Trey focuses on venture opportunities in the healthcare sector, including medical devices, diagnostics, biopharmaceuticals, digital health, technology-enabled healthcare services, and healthcare IT.
Before joining Norwest, Trey was a part of the strategy and business development team at Senti Biosciences, a next-generation cell and gene therapy company that is developing gene circuits to reprogram cells with biological logic to sense inputs, compute decisions, and respond to their cellular environments. Previously, Trey held positions with the life sciences group at Wells Fargo Securities in San Francisco and the Pfizer Neuroscience Research Unit in Cambridge, MA.
Trey obtained bachelor of arts degrees in both neuroscience and economics from Dartmouth College. He is currently enrolled in a Masters in Biomedical Informatics at Stanford Medical School through the Honors Cooperative (work/study) Program.